Compare EME & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EME | KVUE |
|---|---|---|
| Founded | 1987 | 2022 |
| Country | United States | United States |
| Employees | 25000 | N/A |
| Industry | Engineering & Construction | Specialty Chemicals |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7B | 33.6B |
| IPO Year | 1994 | 2023 |
| Metric | EME | KVUE |
|---|---|---|
| Price | $883.15 | $17.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $831.67 | $19.45 |
| AVG Volume (30 Days) | 277.5K | ★ 15.9M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | 0.18% | ★ 4.74% |
| EPS Growth | 30.99 | ★ 40.74 |
| EPS | ★ 28.19 | 0.76 |
| Revenue | ★ $16,986,422,000.00 | $15,124,000,000.00 |
| Revenue This Year | $7.85 | $4.85 |
| Revenue Next Year | $7.05 | $2.63 |
| P/E Ratio | $31.35 | ★ $23.07 |
| Revenue Growth | ★ 16.62 | N/A |
| 52 Week Low | $374.64 | $14.02 |
| 52 Week High | $888.05 | $25.17 |
| Indicator | EME | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 73.23 | 55.72 |
| Support Level | $600.37 | $17.13 |
| Resistance Level | N/A | $19.07 |
| Average True Range (ATR) | 21.08 | 0.26 |
| MACD | 8.24 | 0.06 |
| Stochastic Oscillator | 96.41 | 87.50 |
EMCOR Group Inc is a specialty contractor in the United States and a provider of electrical and mechanical construction and facilities services, building services, and industrial services. Its services are provided to a broad range of commercial, technology, manufacturing, industrial, healthcare, utility, and institutional customers through approximately 100 operating subsidiaries. The company's operating subsidiaries are organized into reportable segments: United States mechanical construction and facilities services, which derives key revenue; United States electrical construction and facilities services; United States building services; United States industrial services; and United Kingdom building services. Geographically, its key revenue is derived from the United States.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.